If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. “Pharma Bro” Martin Shkreli is one of the most disliked people living in the United ...

Why do they call Martin shkreli Pharma Bro? Mr. Shrkeli played a major role in driving up the price of Daraprim, a toxoplasmosis drug, which the Swiss company owns the rights to, earning him the ...

Shkreli had been dubbed "the most hated man in America" for his arrogant and defiant posturing whilst acting as chief executive of Turing Pharma, which hiked the price of off-patent HIV drug ...

Martin Shkreli, the investor and convicted securities fraudster widely referred to as “Pharma Bro,” has claimed that he and Barron Trump, the former president’s youngest son, are behind the ...

On Thursday, Martin Shkreli was told he would face trial for fraud -- but the pharmaceutical executive appeared to have other, more pressing issues on his mind. On the top of that list was ...

Jury selection kicked off Monday in New York for the next chapter of a federal securities trial that could open up the cell adjoining convicted fraudster Martin Shkreli’s for his former lawyer.

In a Spaces interview on X, 'Pharma Bro' Martin Shkreli alleged that he created the DJT cryptocurrency with Barron Trump. Convicted Pharma Bro Martin Shkreli makes surprise appearance at SBF trial ...

Martin Shkreli, colloquially known as “Pharma Bro,” claims that Barron Trump, the 18-year-old son of former President Donald Trump, initiated the TrumpCoin (CRYPTO: DJT) token with his father ...

Former hedge fund manager Martin Shkreli cast doubt on recent quantum computing advances and stock valuations, particularly targeting IonQ Inc. IONQ and Rigetti Computing Inc. RGTI in a series of ...

A New York federal judge ordered Martin Shkreli to surrender any copies of the one-of-a-kind Wu-Tang Clan album "Once Upon a Time in Shaolin" in response to a complaint from the record's new owner.

Martin Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran. Martin ...